Cord Blood Banking Services Market Size & Outlook, 2025-2033

Cord Blood Banking Services Market Overview

The global cord blood banking services market size was valued at USD 2.01 billion in 2024 and is anticipated to grow from USD 2.21 billion in 2025 to reach USD 7.64 billion in 2033, growing at a CAGR of 13.8% during the forecast period (2025–2033). The expanding awareness of stem cell therapeutic potential and the rising incidence of hematological and chronic disorders are primary drivers of growth.

Key Market Indicators

• North America dominated the cord blood banking services industry and accounted for a 42% share in 2024.
• Based on bank type, the private segment held the largest share, around 44.95% of the market in 2024, with high fees, strong marketing, and rising demand, though public banks offer compatibility benefits.
• Based on application, the cancer segment leads cord blood banking, driven by rising transplants for leukemia and related disorders.
• Based on services, the collection & transportation segment dominates cord blood banking, driven by hospital-based procedures and specialized service availability.

Market Size & Forecast

• 2024 Market Size: USD 2.01 billion
• 2033 Projected Market Size: USD 7.64 billion
• CAGR (2025–2033): 13.8%
• Largest market in 2024:  North America
• Fastest-growing region: Asia Pacific

Hematopoietic stem cells, which are individual cells found in cord blood, can be used to treat various invasive diseases. More than 70 diseases, including those affecting the immune system, genetic disorders, neurological conditions, and some types of cancer, can be treated using cord blood. For a child's and a family's future health, cord blood banking is crucial. Parents who want to store their baby's placenta and umbilical cord blood as insurance to help with future medical needs can use cord blood banking services. It can also be applied to other biologically related kids, whether they are members of their own family or not.

Red blood cells, white blood cells, platelets, and plasma are all in cord blood in the exact quantities as in regular blood. It is unique because it is also abundant in hematopoietic stem cells, which are individual blood-forming cells similar to bone marrow. These cells can aid in the treatment of numerous diseases. One of the main factors influencing the market is the rising incidence of various cancers, such as lymphoma and leukemia, brought on by more extended workdays, stressful lifestyles, and excessive smoking and alcohol consumption. Additionally, the use of cord blood banking services for treating immunodeficiency disorders is growing globally.

To get more insights about this report Download Free Sample Report

Cord Blood Banking Services Market Drivers

Growing Awareness of Stem Cells' Therapeutic Potential

Global public awareness of the therapeutic potential of stem cells is growing as more clinical evidence is available. Furthermore, stem cells effectively treat more than 80 diseases and conditions, such as cancer, immunodeficiency diseases, metabolic disorders, and degenerative neuromuscular disorders. During the study period, it is anticipated that public awareness and the adoption of stem cell therapies, as well as stem cell banking services, will increase due to the continued rise in per capita disposable income in developing countries and an anticipated reduction in the costs of the products associated with these treatments. The banking of cord blood has rapidly expanded in the developed nations of the U.S., Europe, and other continents due to a rise in pregnant parents' awareness of the practice. Customers in developing regions cannot afford the high prices and complicated cord blood banking procedure. Numerous public and private organizations are starting awareness campaigns in developing nations like Brazil, China, and India.

Growth in Hematological Disorders and Chronic Diseases

The government providing funds and investments for public storage, an increase in fatal chronic disease incidences, an increase in research activities for the development of various applications of cord blood, and an increase in public awareness of the prevalence of advanced therapeutics are just a few of the factors that drive the growth of the cord blood and cell banking market in the forecast period. The hematological disorder is connected to blood and the organs that produce blood. These illnesses are becoming increasingly common, including thalassemia, sickle cell anemia, leukemia, lymphoma, hemophilia, and others. The world's leukemia cases are increasing dramatically, driving the need for cord blood cells.

Market Restraint

Stringent Rules & Regulations and High Cost

Although it has been established that taking cord blood is painless and safe for both mother and child, the cost of private banking can be a significant barrier to using this service, particularly in developing and underdeveloped nations. Testing for infectious diseases, typing, and contamination are some of these charged services. Another significant obstacle to expanding this business is the strict rules and regulations governing services for cord blood banking. Additionally, it is anticipated that increasingly strict and mandatory regulatory requirements for stem cell preservation and banking, along with the lengthy licensing/approval process for establishing stem cell banks in developed countries, will add to the overall operational costs for stem cell banking service providers.

Market Opportunity

An Increase in Government Funding with A High Incidence of Genetic Disorders

Services for cord blood banking are primarily utilized to cure hereditary diseases like cancer and others. The market for cord blood banking services is projected to expand due to the high frequency of various cancers. Lymphoma, leukemia, immune disorders, and sarcoma cases have increased in recent years in nations like the United States, China, India, and European nations. The World Health Organization reports approximately 509,590 new cases of non-Hodgkin lymphoma and 248,724 deaths resulting from this disease. The demand for cord blood banking services is rising as the number of cancer patients increases. Another critical factor propelling the growth of the coed blood banking market during the anticipated period is rising government funding. The National Institutes of Health invested thirty-eight million dollars in cord blood cell research.

Regional Insights

North America held the largest share of the cord blood banking services industry, accounting for 42% in 2024, and remains the most significant regional market, projected to expand at a CAGR of 12.92% during the forecast period.

According to the American Cancer Society's latest data for 2025, approximately 22,010 people in the United States will be diagnosed with acute myeloid leukemia (AML), and about 11,090 people are expected to succumb to it  This represents a slight increase from the 2024 estimates of 20,800 diagnoses and 11,220 deaths. The US population is sure to adopt solution which help diminish these numbers.  

 Because therapeutic applications have advanced, people are becoming more aware of the advantages of banking cord blood and cells. It is because more people are becoming aware of beneficial cord blood treatments.  

The North American stem cell banking market is expanding as a result of factors including an expanding network of stem cell banking services throughout the region, ongoing approval of stem cell lines for disease treatment (particularly for hematopoietic and autoimmune disorders), recent technological advancements in the field of stem cell collection and preservation techniques, and rising public-private investments for stem cell research. Governments from several nations are heavily funding research and development (R&D) initiatives to support cord blood stem cell clinical trials.

Asia Pacific Market Trends

Asia Pacific is expected to grow at a CAGR of 14.6% during the forecast period. China, India, Japan, Australia, and the rest of Asia-Pacific are all included in the analysis of the Asia-Pacific cord blood banking services market.  

Due to the vast population base and expanding healthcare infrastructure. The market is anticipated to grow in the upcoming years due to the rising prevalence of several chronic diseases, such as blood cancer, cardiac conditions, and several autoimmune diseases.  

Because developing nations like China, Japan, India, and Hong Kong are present, some of the factors anticipated to drive the Asia Pacific cord blood banking services market include rising healthcare investments and increased investments by international players to maximize geographic reach and thereby expand market share. Additionally, a thriving medical tourism sector is anticipated to boost demand for CB units in this area.

Europe Market Trends

The European cord blood banking services market is also growing tremendously. This growth can be attributed to an increased prevalence of chronic diseases such as cancer and diabetes. According to the International Diabetes Federation (IDF) in Europe, approximately 65.6 million adults (ages 20–79) were living with diabetes. The presence of a well-established network of cord blood banks in the region will serve as a boon for diabetic patients.  

The cord blood banking services market in Germany holds a significant position in the European region. The growth of the cord blood banking market is due to rising rates of genetic abnormalities, helpful government regulations, increasing disposable income, and healthcare expenditure. 

The UK cord blood banking services market is expected to grow rapidly in the coming years, owing to the presence of key companies in the region and high technological advancements. 

Bank Type Insights

The private segment is the highest contributor to the market and is expected to grow at a CAGR of 13.46% during the forecast period. It is because parents are charged a high price for the collection and storage of CB units. Furthermore, private players' customer bases are growing compared to public banks due to their marketing strategies. When all the elements above were considered, the private banking service segment dominated the global market. Some critical elements anticipated to drive the growth of the public banks shortly include greater chances of finding a compatible match for the patient's blood and the risk of the blood unit stored in private banks not being usable.

Application Insights

The global market is bifurcated into cancer, blood disorders, bone marrow failure syndrome, immunodeficiency disorders, and metabolic disorders. The cancer segment is the highest contributor to the market and is expected to grow at a CAGR of 13.9% during the forecast period. Cord blood stem cell transplants have been used to treat adult and pediatric cancer. Over 35,000 cord blood transplants have taken place globally, most of which were performed to treat leukemia and other blood abnormalities. The crucial qualification is that donors, NOT the child's cord blood, must be used for cord blood transplants in children with leukemia or other blood disorders. Visit Parents' Guide to Cord Blood Foundation at to learn more about cord blood banking.

Services Insights

The collection & transportation segment is the highest contributor to the market and is expected to grow at a CAGR of 13.3% during the forecast period. An obstetrician-gynecologist (ob-gyn) or the professionals at the hospital where you give birth will collect the cord blood. The umbilical cord is severed and clamped after delivery. With a needle with a bag attached, blood is extracted from the cord. It takes about 10 minutes to complete. Not all medical centers provide this service. Some impose an additional charge that might or might not be covered by insurance.

List of key players in Cord Blood Banking Services Market

1. Cordlife Group Limited (Singapore)
2. CBR Systems Inc. (U.S.)
3. Cryo-Cell International Inc (U.S.).
4. Cryo-Save AG (Netherlands)
5. Lifeforce Cryobanks(U.S.)
6. National Cord Blood Program(U.S.)
7. ViaCord Inc.(U.S.)
8. Virgin Health Bank(U.K).

To get more findings about this report Download Market Share

Recent Developments

• In August 2025, CytoMed Therapeutics Limited introduced LongevityBank, a dedicated cord blood banking facility aimed at expanding its cord-blood-derived immunotherapy platform. The initiative plans to invest up to US$500,000 to advance the preservation of clinical-scale natural killer (NK) cells from cord blood units, enhancing their therapeutic applications.
• In August 2025, Cryo-Cell International, the world’s largest family cord blood bank, adopted GE Healthcare’s AutoXpress™ System to automate key production steps for its cord blood stem cell units, improving both efficiency and scalability.
• In April 2025, U.S. Representative Jodey C. Arrington introduced the Family Cord Blood Banking Act (H.R.2810) in the 119th Congress, proposing that costs for private umbilical cord blood or tissue banking be treated as medical care expenses under the Internal Revenue Code.
• From August 2024 to January 2025, Singapore’s Ministry of Health allowed Cordlife Group Limited to resume cord blood banking services under strict conditions, limiting the collection, testing, processing, and storage to only 30 new cord blood units per month after confirming compliance with essential regulatory requirements.